Growth Update - Turner Syndrome Practice Updates

Speciality: Physician (Internal Medicine)


Speaker:

Dr. Ahila Ayyavoo - Moderator | DCH, DNB (Paed), PhD Consultant, Paediatric Endocrinologist

Dr. Soundaram V - Speaker | Consultant Paediatric Endocrinologist,

Dr. Shobi Anandi V - Speaker | MD (Ped); DNB (Ped); Fellowship in Pediatric and Adolescent Endocrinology, Consultant Pediatric Endocrinologist

Description:

A warm welcome to all the medical professionals in this interesting session on Growth Update - Turner Syndrome Practice Updates
Turner Syndrome (TS) is a chromosomal disorder affecting females, characterized by partial or complete loss of one X chromosome. Recent practice updates emphasize the importance of early diagnosis and intervention to optimize growth and development outcomes. Growth hormone (GH) therapy has become a cornerstone in managing short stature associated with TS, with evidence showing significant improvements in height when initiated at an early age. Regular monitoring and individualized dosing are critical to maximize the benefits of GH therapy while minimizing potential side effects.
Advancements in genetic testing have improved the accuracy and speed of diagnosing Turner Syndrome, allowing for earlier and more precise interventions. These updates also highlight the importance of a multidisciplinary approach in managing TS, addressing not only growth concerns but also associated comorbidities such as cardiovascular, renal, and reproductive health issues. Comprehensive care plans involving endocrinologists, cardiologists, nephrologists, and reproductive specialists are essential to provide holistic care for individuals with TS.
Therefore, get an overall knowledge of Growth Update - Turner Syndrome Practice Updates
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients face high out-of-pocket costs after incident cancer diagnosis

2.

In a study, immune detection of oral cancers is linked to obesity.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Common intracellular toxin could help fight leukemia


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot